Stock Comparison
CRL vs DHR
Charles River Laboratories and Danaher Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.97B
$140.31B
P/E (TTM)
—
35.6
Forward P/E
24.5
23.4
Price/Sales
3.3
5.6
Price/Book
4.6
2.7
EV/EBITDA
71.0
21.5
Dividend Yield
—
0.51%
Profitability
Net Margin
-4.59%
14.89%
Operating Margin
11.77%
20.95%
Return on Equity
-7.52%
7.61%
Return on Assets
4.11%
3.95%
Growth (YoY)
Revenue Growth
-2.70%
5.50%
Earnings Growth
-17.30%
59.70%
Price & Risk
Beta
1.4
0.8
52-Week High
$284.41
$241.52
52-Week Low
$145.57
$161.91
Analyst Target
$270.86
$227.96
Compare CRL and DHR your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.